Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.

NCT01258439 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

HIV
Cardiovascular Disease

Interventions

DRUG: raltegravir plus truvada
DRUG: Darunavir, ritonavir, tenofovir/emtricitabine (Truvada)

Sponsor

St Vincent's Hospital, Sydney

Collaborators

[object Object]